Volta Labs and Ginkgo Bioworks (DNA) announced the integration of the Callisto Sample Prep System at Ginkgo Bioworks as part of the routine ...
Ginkgo Bioworks faces ongoing revenue declines and high cash burn, despite cost-cutting efforts and partnerships with major firms like Pfizer and Merck. The company's Q3 2024 revenue was inflated ...
The first stage of the review process is a draft chemical risk assessment. We have completed the draft assessment of Gingko biloba extract. We’re proposing that it may be harmful to human health when ...